While current schizophrenia medications often help control symptoms like hallucinations, delusions, and paranoia, they don't always help with cognitive impairments often noted in patients with schizophrenia, such as those associated with attention, memory, understanding, or reasoning.
As a result, local doctors are conducting a medical research study of an experimental drug that is taken along with a person's current schizophrenia medication. In this study, they want to evaluate the safety and effectiveness of the experimental drug to see if it helps with cognitive impairments.
Because the experimental drug will be an add-on drug to current treatment, you will continue taking your regular medication while in the study and will not be asked to change or stop taking this medication at any time.
To pre-qualify for this study, you must be:
18-50 years of age
Medically diagnosed with schizophrenia for at least 3 years
Receiving a stable dose of an antipsychotic drug (other than clozapine) for at least 8 weeks prior to the study
In a stable living situation and have someone who can provide information about you to study doctors and staff members
All study-related visits, tests, and study drug will be provided to participants at no cost. In addition, reimbursement for study-related time and travel may be provided.
To learn more, please contact:
Integrative Clinical Trials
Michael Yuryev, DO
718-444-7774 ext: 101
